The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of AC Immune SA (NASDAQ: ACIU) was $3.67 for the day, down -0.81% from the previous closing price of $3.7. In other words, the price has decreased by -$0.81 from its previous closing price. On the day, 0.51 million shares were traded. ACIU stock price reached its highest trading level at $3.68 during the session, while it also had its lowest trading level at $3.5.
Ratios:
Our analysis of ACIU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 1.16. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on May 31, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 03 ’25 when ANDREA M.A PFEIFER bought 45,000 shares for $3.13 per share.
ANDREA M.A PFEIFER bought 35,000 shares of ACIU for $83,300 on Sep 12 ’25. On Jul 24 ’25, another insider, ANDREA M.A PFEIFER, who serves as the Officer of the company, bought 20,000 shares for $2.34 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACIU now has a Market Capitalization of 369202016 and an Enterprise Value of 266472944. For the stock, the TTM Price-to-Sale (P/S) ratio is 70.51 while its Price-to-Book (P/B) ratio in mrq is 4.12. Its current Enterprise Value per Revenue stands at 60.95 whereas that against EBITDA is -3.719.
Stock Price History:
The Beta on a monthly basis for ACIU is 1.67, which has changed by 0.40151513 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, ACIU has reached a high of $4.00, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is 16.06%, while the 200-Day Moving Average is calculated to be 50.47%.
Shares Statistics:
ACIU traded an average of 706.09K shares per day over the past three months and 479870 shares per day over the past ten days. A total of 88.04M shares are outstanding, with a floating share count of 60.78M. Insiders hold about 38.57% of the company’s shares, while institutions hold 24.82% stake in the company. Shares short for ACIU as of 1767139200 were 3346927 with a Short Ratio of 4.74, compared to 1764288000 on 1848164. Therefore, it implies a Short% of Shares Outstanding of 3346927 and a Short% of Float of 7.0199996.
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. Analysts are recommending an EPS of between -$0.68 and -$0.7 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.61, with 2.0 analysts recommending between -$0.5 and -$0.71.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for ACIU’s current fiscal year. The highest revenue estimate was $6M, while the lowest revenue estimate was $3.23M, resulting in an average revenue estimate of $4.4M. In the same quarter a year ago, actual revenue was $27.31MBased on 3 analysts’ estimates, the company’s revenue will be $32.75M in the next fiscal year. The high estimate is $90M and the low estimate is $3.24M.
